Mild dilatation of the main pancreatic duct, even without an obvious mass, is a risk factor for pancreatic cancer in ...

UCLA researchers have developed a CAR-NKT cell therapy that has been more effective than current immunotherapies at fighting ...

A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist ...

Doctors may soon have a new tool in the fight against one of the most aggressive and lethal forms of cancer—in the form of an 'early warning' signature of precancerous cells. This is the promise of a ...